Cystic Fibrosis is going down

On July 18th, Vertex Pharmaceuticals announced positive early study results for next-generation CFTR modulators. Why is this exciting news? Because this is what many of us with cystic fibrosis have been waiting for: a medicine that will treat the underlying issue of the disease for those of us who have a minimal function mutation. While patient accessibility is still a little ways off, the bottom line is, these medicines are going to drastically change lives! Here is Vertex’ press release and then the Cystic Fibrosis Foundation announcement is here.

This entry was posted in Health Insurance / Medical Insurance, Life, Research and Fundraising, Respiratory / Asthma and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *